| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.057 | 0.07 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.06 | 0.07 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.095 | 0.08 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.13 | 0.09 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |